
Sign up to save your podcasts
Or


In the second part of this two-part series, Dr. Kaitlyn Palmer explains how these biomarkers change our approach to diagnosing multiple sclerosis.
Show reference:
Diagnosis of multiple sclerosis: 2024 revisions of the McDonald criteria. Montalban, Xavier, et al. The Lancet Neurology, Volume 24, Issue 10, 850 - 865
By American Academy of Neurology4.8
132132 ratings
In the second part of this two-part series, Dr. Kaitlyn Palmer explains how these biomarkers change our approach to diagnosing multiple sclerosis.
Show reference:
Diagnosis of multiple sclerosis: 2024 revisions of the McDonald criteria. Montalban, Xavier, et al. The Lancet Neurology, Volume 24, Issue 10, 850 - 865

318 Listeners

496 Listeners

293 Listeners

50 Listeners

296 Listeners

3,340 Listeners

12 Listeners

1,150 Listeners

23 Listeners

194 Listeners

92 Listeners

513 Listeners

368 Listeners

190 Listeners

81 Listeners